Literature DB >> 21196439

Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment.

N Funel, E Vasile, M Del Chiaro, U Boggi, A Falcone, D Campani, A Scarpa, E Giovannetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21196439     DOI： 10.1093/annonc/mdq686

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Role of CYB5A in pancreatic cancer prognosis and autophagy modulation.

Authors:  Elisa Giovannetti; Qiuyan Wang; Amir Avan; Niccola Funel; Tonny Lagerweij; Jih-Hsiang Lee; Viola Caretti; Arjan van der Velde; Ugo Boggi; Yisong Wang; Enrico Vasile; Godefridus J Peters; Thomas Wurdinger; Giuseppe Giaccone
Journal:  J Natl Cancer Inst       Date:  2013-12-03       Impact factor: 13.506

2.  Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.

Authors:  Elena Galvani; Elisa Giovannetti; Francesca Saccani; Andrea Cavazzoni; Leticia G Leon; Henk Dekker; Roberta Alfieri; Caterina Carmi; Marco Mor; Andrea Ardizzoni; Pier Giorgio Petronini; Godefridus J Peters
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

3.  Pancreatic cancer: Animal model and molecular biology.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2011-10

4.  Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.

Authors:  Huanwen Wu; Liang Zhu; Hui Zhang; Xiaohua Shi; Li Zhang; Wenze Wang; Huadan Xue; Zhiyong Liang
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.